Susie Q Lew

Dr. Susie Q Lew

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
SLSusie Q Lew
Susie Q Lew
EWEric L. Wallace
Eric L. Wallace
VSVesh Srivatana
Vesh Srivatana
BWBradley A. Warady
Bradley A. Warady
SWSuzanne Watnick
Suzanne Watnick
MSMartin J. Schreiber
Martin J. Schreiber

1 January 2010 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
PDF file
SLSusie Q Lew
Susie Q Lew
Hydrothorax in a patient treated with peritoneal dialysis (PD) poses a diagnostic dilemma. Hydrothorax due to migration of dialysis fluid across the diaphragm and into the pleural space creates a serious complication of PD but generally does not threaten life. Shortness of breath causes the patient to seek medical attention. A sudden diminution in dialysis adequacy or poor ultrafiltration rate constitutes a unique marker for patients treated with PD compared to the general population. This article reviews the etiology for hydrothorax specifically in the PD population. Thoracentesis with chemical analysis of the fluid, imaging studies with and without contrast or markers, and video-assisted thoracoscopic surgery play important roles in the evaluation of hydrothorax. A conservative PD regimen, surgical intervention, and pleurodesis provide treatment options to those receiving PD.

1 July 2019 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
SLSusie Q Lew
Susie Q Lew
NSNeal Sikka
Neal Sikka

Verified
Journal Article
Open access
PDF file
FAFahad Aziz
Fahad Aziz
RSRamin Sam
Ramin Sam
SLSusie Q Lew
Susie Q Lew
LMLarry Massie
Larry Massie
MMMadhukar Misra
Madhukar Misra
ATAntonios Helias Tzamaloukas
Antonios Helias Tzamaloukas
Pseudohyponatremia remains a problem for clinical laboratories. In this study, we analyzed the mechanisms, diagnosis, clinical consequences, and conditions associated with pseudohyponatremia, and future developments for its elimination. The two methods involved assess the serum sodium concentration ([Na]S) using sodium ion-specific electrodes: (a) a direct ion-specific electrode (ISE), and (b) an indirect ISE. A direct ISE does not require dilution of a sample prior to its measurement, whereas an indirect ISE needs pre-measurement sample dilution. [Na]S measurements using an indirect ISE are influenced by abnormal concentrations of serum proteins or lipids. Pseudohyponatremia occurs when the [Na]S is measured with an indirect ISE and the serum solid content concentrations are elevated, resulting in reciprocal depressions in serum water and [Na]S values. Pseudonormonatremia or pseudohypernatremia are encountered in hypoproteinemic patients who have a decreased plasma solids content. Three mechanisms are responsible for pseudohyponatremia: (a) a reduction in the [Na]S due to lower serum water and sodium concentrations, the electrolyte exclusion effect; (b) an increase in the measured sample’s water concentration post-dilution to a greater extent when compared to normal serum, lowering the [Na] in this sample; (c) when serum hyperviscosity reduces serum delivery to the device that apportions serum and diluent. Patients with pseudohyponatremia and a normal [Na]S do not develop water movement across cell membranes and clinical manifestations of hypotonic hyponatremia. Pseudohyponatremia does not require treatment to address the [Na]S, making any inadvertent correction treatment potentially detrimental.

20 December 2012 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
OIO. Susan Iheagwara
O. Susan Iheagwara
TITodd S. Ing
Todd S. Ing
CKCarl M. Kjellstrand
Carl M. Kjellstrand
SLSusie Q Lew
Susie Q Lew

1 May 2007 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Open access
PDF file
SLSusie Q Lew
Susie Q Lew
Hemoperitoneum is seen in patients receiving peritoneal dialysis (PD) because the PD catheter provides a window to the peritoneum. Gynecological associated phenomena account for the majority of cases. Intra-abdominal pathology of solid organs such as the kidney, liver, and spleen as well as the gastrointestinal tract is recognized. Unique to PD patients, hemoperitoneum may be associated with the catheter itself, uremic bleeding, or peritonitis. A successful PD program requires nephrologists, PD nurses, and patients assess and manage hemoperitoneum in a systematic fashion. This paper reviews hemoperitoneum in adult PD patients.